Jan Ilkowski
Impact in
- Physiology top 1%
- Alzheimer's disease research and treatments
- Psychiatry and Mental health top 2%
- Dementia and Cognitive Impairment Research
Papers in
- Physiology 10
- Alzheimer's disease research and treatments 9
-
- Myasthenia Gravis and Thymoma 2
- Neuroinflammation and Neurodegeneration Mechanisms 1
- Co-authors
- Jacek Losy (1 shared paper)Jolanta Dorszewska (3 shared papers)Teresa Grzelak (2 shared papers)Michał Prendecki (3 shared papers)Marta Kowalska (2 shared papers)Katarzyna Białas (2 shared papers)Wojciech P. Kozubski (3 shared papers)Maria Styczyńska (2 shared papers)
- Journals
- The Lancet Neurology (3 papers)Neurology (2 papers)The Lancet (1 paper)Journal of Alzheimer s Disease (1 paper)Oncotarget (1 paper)
- Partner nations
- PolandUnited StatesSweden
In The Last Decade
Jan Ilkowski
16 papers receiving 2.9k citations
Jan Ilkowski's Hit Papers
Peers
Comparison fields: 5 of 94
- Physiology 1.3k
- Psychiatry and Mental health 906
- Pathology and Forensic Medicine 400
- Neurology 297
- Neurology 154
Countries citing papers authored by Jan Ilkowski
This map shows the geographic impact of Jan Ilkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Ilkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Ilkowski more than expected).
Fields of papers citing papers by Jan Ilkowski
This network shows the impact of papers produced by Jan Ilkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Ilkowski. The network helps show where Jan Ilkowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Ilkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Donanemab in Early Symptomatic Alzheimer Disease Hit paper breakdown → | 2023 | 1799 |
| 2 | Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension Hit paper breakdown → | 2018 | 286 |
| 3 | Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study Hit paper breakdown → | 2023 | 178 |
| 4 | Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease Hit paper breakdown → | 2022 | 156 |
| 5 | 2019 | 143 | |
| 6 | 2017 | 86 | |
| 7 | 2003 | 85 | |
| 8 | 2023 | 79 | |
| 9 | Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke. | 2006 | 50 |
| 10 | 2018 | 42 | |
| 11 | 2018 | 34 | |
| 12 | 2019 | 32 | |
| 13 | 2018 | 30 | |
| 14 | 2025 | 3 | |
| 15 | 2019 | 1 | |
| 16 | 2026 | 1 | |
| 17 | 2025 | 0 |
About Jan Ilkowski
Jan Ilkowski is a scholar working on Physiology, Neurology, Pathology and Forensic Medicine, Infectious Diseases and Neurology, having authored 17 papers that have together received 3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), COVID-19 Clinical Research Studies (2 papers), Myasthenia Gravis and Thymoma (2 papers), Multiple Sclerosis Research Studies (2 papers), Epigenetics and DNA Methylation (1 paper), Acute Ischemic Stroke Management (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Physiology (1.3k citations), Psychiatry and Mental health (906 citations), Pathology and Forensic Medicine (400 citations), Neurology (297 citations) and Neurology (154 citations). Jan Ilkowski has collaborated with scholars based in Poland, United States and Sweden. Frequent co-authors include Jacek Losy, Jolanta Dorszewska, Teresa Grzelak, Michał Prendecki, Marta Kowalska, Katarzyna Białas, Wojciech P. Kozubski, Maria Styczyńska, Maria Barcikowska and Anna K. Barczak. Their work appears in journals such as The Lancet Neurology, Neurology, The Lancet, Journal of Alzheimer s Disease and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.